DHL Global Forwarding, the air and ocean freight division of Deutsche Post DHL Group, is working with the International Air Transport Association (IATA) to implement the latest industry standards for the transportation of goods for the life sciences and healthcare sectors.
DHL will look to attain IATA’s CEIV Pharma Certification for 30 of its Air Thermonet facilities, located at various hubs and airports around the world. DHL’s Global Forwarding station in Brussels, Belgium, has already achieved the certification after a series of independent audits and training sessions by IATA. The certification encompasses IATA Temperature Control Regulations (TCR), European Union Goods Distribution Practices (EU GDP), World Health Organization Annex 5 and US Pharmacopeia Standards.
David Bang, global head of DHL Temperature Management Solutions, DHL Global Forwarding, said, “As global demand for structurally complex, temperature-sensitive pharmaceutical products grows, the life sciences and healthcare sector faces the challenges of increasingly strict regulations and the need for smart cold chains that can secure product integrity and patients’ safety. The IATA CEIV certification is yet another initiative within part of our continuous improvement activities to ensure our specialized and compliant network is up to the latest quality standard, which recommends DHL as the right partner to the life sciences and healthcare sector.”
Glyn Hughes, global head of cargo, IATA, said, “DHL’s commitment to join the CEIV pharma program and certify its key global Thermonet facilities is good news for customers, who can have even more confidence that their life-saving and temperature-sensitive products will be delivered in impeccable condition. For the industry, it is another step toward achieving industry alignment and standardization across the pharmaceutical logistic supply chain, further enhancing the capabilities of the global pharma network.”
May 31, 2016